(PharmaNewsWire.Com, July 11, 2017 ) European market has taken initiative towards harmonisation as they ensure that every bio bank follows the norms for collecting, storing and distributing samples. The market is facilitated by number of collaborators from government and private organisations. Germany is the biggest market in Europe followed by UK.
Biobank stores the biological samples (mainly human samples) used for research purposes or even for treatment and serves as a biorepository. Before biobanks came into the market doctors use to collect the samples only for their own research purpose but the biobanks gave researchers access to data representing a large amount of people. The wide range of bio specimens includes samples of blood, saliva, plasma, and purified DNA which can be described as libraries of the human organism.
For the industrial development of diagnostics and therapeutics as well as for medical research biological material and related data have become an important resource. There is an inclination in the market for Bio preservation systems due to increase in demand for tissue banking, stem cell banking and umbilical cord banking.
The key driver for the European market is poor productivity rate of the pharmaceutical industry with respect to the new drug approvals. The vision of personalized medicine is also endorsed for the growth of this market. These storage solutions can reduce the testing time and costs for manufacturers, as a testing laboratory can take up to 3 days for testing but if the hospital themselves have the storage bank the time can reduce to 3 hours. The major drawbacks involve storage and handling problem, regulatory issues and cost competitive procedures.
This market is segmented majorly on the basis of sample type and product type. Sample type includes human tissues, stem cells, DNA or RNA, Bio-fluids and others whereas product type is subdivided into types of equipment’s (Temperature control systems, Incubators, Centrifuges, Alarm and Monitoring Systems, Accessories and Other Equipment) and consumables. Based on Application they are divided into Therapeutic Applications, Research Applications and Clinical Trials. The human tissues section is expected to account for the highest market share of approximately 65% during the forecast period. Preference for human tissue specimens is increasing over animal tissue samples due to unavailability of appropriate animal models for some specific neurological and psychiatric disorders.
The key players in the bio preservation market are Beckman Coulter, Tecan group, Taylor- Wharton, Panasonic biomedical, Teva pharmaceuticals, Biolife solutions, Custom biogenic systems, Princeton cryotech, Fluidx, Tissue solutions, Wildcat laboratory solutions, Micronik and Brooks life science systems.
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
